Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay

Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the sensitivity and specificity of the Xpert HCV Viral Load Finger-Stick assay (Xpert HCV VL FS) for HCV RNA detection (finger-stick) and the Xpert HCV Vi...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 217; no. 12; pp. 1889 - 1896
Main Authors Lamoury, Francois M J, Bajis, Sahar, Hajarizadeh, Behzad, Marshall, Alison D, Martinello, Marianne, Ivanova, Elena, Catlett, Beth, Mowat, Yasmin, Marks, Philippa, Amin, Janaki, Smith, Julie, Ezard, Nadine, Cock, Victoria, Hayllar, Jeremy, Persing, David H, Kleman, Marika, Cunningham, Philip, Dore, Gregory J, Applegate, Tanya L, Grebely, Jason
Format Journal Article
LanguageEnglish
Published United States 25.05.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the sensitivity and specificity of the Xpert HCV Viral Load Finger-Stick assay (Xpert HCV VL FS) for HCV RNA detection (finger-stick) and the Xpert HCV Viral Load assay (plasma) compared with the Abbott RealTime HCV Viral Load assay by venepuncture. Plasma and finger-stick capillary whole-blood samples were collected from participants in an observational cohort in Australia. Of 223 participants enrolled, HCV RNA was detected in 40% of participants (85 of 210) with available Xpert HCV Viral Load testing. Participants receiving HCV therapy were excluded from subsequent analyses (n = 16). Sensitivity of the Xpert HCV Viral Load assay for HCV RNA quantification in plasma collected by venepuncture was 100.0% (95% confidence interval [CI] 96.9%-100.0%) and specificity was 100.0% (95% CI, 94.4%-100.0%). Sensitivity of the Xpert HCV VL FS assay for HCV RNA quantification in samples collected by finger-stick was 100.0% (95% CI, 93.9%-100.0%) and specificity was 100.0% (95% CI, 96.6%-100.0%). The Xpert HCV VL FS test can accurately detect active infection from a finger-stick sample in 1 hour allowing single-visit HCV diagnosis.
AbstractList Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the sensitivity and specificity of the Xpert HCV Viral Load Finger-Stick assay (Xpert HCV VL FS) for HCV RNA detection (finger-stick) and the Xpert HCV Viral Load assay (plasma) compared with the Abbott RealTime HCV Viral Load assay by venepuncture. Plasma and finger-stick capillary whole-blood samples were collected from participants in an observational cohort in Australia. Of 223 participants enrolled, HCV RNA was detected in 40% of participants (85 of 210) with available Xpert HCV Viral Load testing. Participants receiving HCV therapy were excluded from subsequent analyses (n = 16). Sensitivity of the Xpert HCV Viral Load assay for HCV RNA quantification in plasma collected by venepuncture was 100.0% (95% confidence interval [CI] 96.9%-100.0%) and specificity was 100.0% (95% CI, 94.4%-100.0%). Sensitivity of the Xpert HCV VL FS assay for HCV RNA quantification in samples collected by finger-stick was 100.0% (95% CI, 93.9%-100.0%) and specificity was 100.0% (95% CI, 96.6%-100.0%). The Xpert HCV VL FS test can accurately detect active infection from a finger-stick sample in 1 hour allowing single-visit HCV diagnosis.
Author Bajis, Sahar
Amin, Janaki
Martinello, Marianne
Ivanova, Elena
Persing, David H
Dore, Gregory J
Cock, Victoria
Lamoury, Francois M J
Marks, Philippa
Smith, Julie
Ezard, Nadine
Grebely, Jason
Hayllar, Jeremy
Catlett, Beth
Kleman, Marika
Hajarizadeh, Behzad
Cunningham, Philip
Marshall, Alison D
Applegate, Tanya L
Mowat, Yasmin
Author_xml – sequence: 1
  givenname: Francois M J
  surname: Lamoury
  fullname: Lamoury, Francois M J
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 2
  givenname: Sahar
  surname: Bajis
  fullname: Bajis, Sahar
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 3
  givenname: Behzad
  surname: Hajarizadeh
  fullname: Hajarizadeh, Behzad
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 4
  givenname: Alison D
  surname: Marshall
  fullname: Marshall, Alison D
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 5
  givenname: Marianne
  surname: Martinello
  fullname: Martinello, Marianne
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 6
  givenname: Elena
  surname: Ivanova
  fullname: Ivanova, Elena
  organization: Foundation for Innovative New Diagnostics, Geneva, Switzerland
– sequence: 7
  givenname: Beth
  surname: Catlett
  fullname: Catlett, Beth
  organization: St Vincent's Applied Medical Research, Darlinghurst, Sydney, New South Wales
– sequence: 8
  givenname: Yasmin
  surname: Mowat
  fullname: Mowat, Yasmin
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 9
  givenname: Philippa
  surname: Marks
  fullname: Marks, Philippa
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 10
  givenname: Janaki
  surname: Amin
  fullname: Amin, Janaki
  organization: Macquarie University, Sydney, New South Wales
– sequence: 11
  givenname: Julie
  surname: Smith
  fullname: Smith, Julie
  organization: Matthew Talbot Hostel, St Vincent de Paul Society New South Wales Support Services, Sydney
– sequence: 12
  givenname: Nadine
  surname: Ezard
  fullname: Ezard, Nadine
  organization: Faculty of Medicine, University of New South Wales, Sydney
– sequence: 13
  givenname: Victoria
  surname: Cock
  fullname: Cock, Victoria
  organization: Drug and Alcohol Services of South Australia, Adelaide
– sequence: 14
  givenname: Jeremy
  surname: Hayllar
  fullname: Hayllar, Jeremy
  organization: Alcohol and Drug Service, Metro North Hospital and Health Service, Brisbane, Queensland, Australia
– sequence: 15
  givenname: David H
  surname: Persing
  fullname: Persing, David H
  organization: Cepheid, Sunnyvale, California
– sequence: 16
  givenname: Marika
  surname: Kleman
  fullname: Kleman, Marika
  organization: Cepheid AB, Solna, Sweden
– sequence: 17
  givenname: Philip
  surname: Cunningham
  fullname: Cunningham, Philip
  organization: St Vincent's Applied Medical Research, Darlinghurst, Sydney, New South Wales
– sequence: 18
  givenname: Gregory J
  surname: Dore
  fullname: Dore, Gregory J
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 19
  givenname: Tanya L
  surname: Applegate
  fullname: Applegate, Tanya L
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
– sequence: 20
  givenname: Jason
  surname: Grebely
  fullname: Grebely, Jason
  organization: The Kirby Institute, UNSW Sydney, Sydney, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29534185$$D View this record in MEDLINE/PubMed
BookMark eNo90M1LwzAcxvEginvRo1fJ0Utc0jRNehxjL8JAQR3eSpr8qpldM5NW2H_vpNPTc_nwHL4jdN74BhC6YfSe0ZxPXFNZFydbd2AsPUNDJrgkWcb4ORpSmiSEqTwfoFGMW0ppyjN5iQZJLnjKlBii5fxb151unW-wr3D7AfhtD6HFq9kGb1zQNV57bfHCNe8QyHPrzCd-8q5pia_ITAfA0xj14QpdVLqOcH3aMXpdzF9mK7J-XD7MpmtiOE9aYkSmSpEZJSXXpaqsVbkynIK0olRS5JAASMXzNAWbCLApL02ZlTyRmVVC8DG663_3wX91ENti56KButYN-C4WCWVcqlQofqSkpyb4GANUxT64nQ6HgtHit13Rtyv6dkd_e7ruyh3Yf_0Xi_8Al9tspw
CitedBy_id crossref_primary_10_1016_j_gtc_2020_01_005
crossref_primary_10_3390_diagnostics11050746
crossref_primary_10_1016_j_lanwpc_2023_100750
crossref_primary_10_1093_cid_ciae156
crossref_primary_10_1016_j_jhep_2020_08_018
crossref_primary_10_1111_liv_14227
crossref_primary_10_3390_v15020521
crossref_primary_10_1093_cid_ciae155
crossref_primary_10_3390_diagnostics13040684
crossref_primary_10_1093_infdis_jiaa574
crossref_primary_10_1038_s41467_021_27076_z
crossref_primary_10_3390_v13112327
crossref_primary_10_1007_s00103_020_03218_4
crossref_primary_10_1080_14787210_2019_1604221
crossref_primary_10_1016_j_drugpo_2024_104317
crossref_primary_10_1016_j_drugpo_2021_103469
crossref_primary_10_1016_j_drugpo_2023_103982
crossref_primary_10_1080_10826084_2020_1846198
crossref_primary_10_1111_jvh_13133
crossref_primary_10_1016_j_jinf_2019_09_010
crossref_primary_10_9778_cmajo_20190068
crossref_primary_10_1016_j_drugpo_2024_104394
crossref_primary_10_1016_j_drugpo_2019_10_012
crossref_primary_10_1016_S0140_6736_23_01320_X
crossref_primary_10_1111_add_16137
crossref_primary_10_17235_reed_2022_8609_2022
crossref_primary_10_1016_j_jceh_2018_12_001
crossref_primary_10_1111_liv_14315
crossref_primary_10_1002_hep4_1826
crossref_primary_10_1002_hsr2_151
crossref_primary_10_1111_dar_13723
crossref_primary_10_1111_liv_15123
crossref_primary_10_3390_diagnostics11081354
crossref_primary_10_1111_liv_14242
crossref_primary_10_1016_j_drugpo_2019_102608
crossref_primary_10_1093_infdis_jiy117
crossref_primary_10_1111_jvh_13786
crossref_primary_10_1093_ofid_ofaa196
crossref_primary_10_1373_clinchem_2019_304782
crossref_primary_10_1186_s12939_024_02209_0
crossref_primary_10_1111_jvh_13268
crossref_primary_10_1016_S2468_1253_21_00471_4
crossref_primary_10_1016_j_drugpo_2019_07_016
crossref_primary_10_1099_jmm_0_001332
crossref_primary_10_1016_j_jcv_2024_105653
crossref_primary_10_1038_s41575_018_0026_5
crossref_primary_10_1136_bmjopen_2022_068604
crossref_primary_10_1093_cid_ciaa571
crossref_primary_10_1016_j_jhep_2023_04_019
crossref_primary_10_1177_17562848211016563
crossref_primary_10_1016_j_ajg_2021_07_002
crossref_primary_10_1021_acs_biomac_3c01187
crossref_primary_10_1093_infdis_jiaa037
crossref_primary_10_1093_infdis_jiad269
crossref_primary_10_1111_jvh_13119
crossref_primary_10_1093_infdis_jiad463
crossref_primary_10_1056_NEJMra1810477
crossref_primary_10_1016_j_eimc_2020_02_003
crossref_primary_10_1111_jvh_13233
crossref_primary_10_3138_canlivj_2019_0007
crossref_primary_10_3390_life13122271
crossref_primary_10_1016_j_drugpo_2019_03_001
crossref_primary_10_1111_jvh_13092
crossref_primary_10_17269_s41997_019_00234_z
crossref_primary_10_57187_smw_2022_40009
crossref_primary_10_1016_j_jsat_2020_108025
crossref_primary_10_1053_j_gastro_2018_10_048
crossref_primary_10_3390_diagnostics11071253
crossref_primary_10_1016_j_drugpo_2020_102734
crossref_primary_10_1016_j_drugpo_2022_103706
crossref_primary_10_1016_j_lana_2023_100490
crossref_primary_10_1093_infdis_jiaa366
crossref_primary_10_1111_liv_15266
crossref_primary_10_1016_j_drugpo_2018_08_011
crossref_primary_10_3390_diagnostics12051255
crossref_primary_10_1080_14737159_2023_2292645
crossref_primary_10_1016_j_drugpo_2021_103456
crossref_primary_10_1016_j_drugpo_2022_103876
crossref_primary_10_1016_j_focus_2024_100185
crossref_primary_10_1016_j_lanwpc_2024_101119
crossref_primary_10_1111_jvh_13002
crossref_primary_10_1007_s40273_021_01064_z
crossref_primary_10_1128_jcm_00771_23
crossref_primary_10_1016_j_idc_2018_02_010
crossref_primary_10_1016_S2468_1253_18_30270_X
crossref_primary_10_1111_jvh_13284
crossref_primary_10_1080_00325481_2020_1717160
Cites_doi 10.1093/cid/cir499
10.1111/jvh.12247
10.1128/JCM.02460-16
10.1177/00333549161310S203
10.1093/infdis/jiv423
10.1016/S2468-1253(17)30075-4
10.1016/j.jcv.2014.09.004
10.1016/j.jcv.2017.01.006
10.1111/jvh.12475
10.1093/infdis/jir422
10.1016/j.drugpo.2017.05.022
10.1016/j.cmi.2016.01.009
10.1016/j.drugpo.2015.07.002
10.1016/j.jcv.2012.04.003
10.1016/j.jhep.2014.07.027
10.1080/09540120701426524
10.7326/0003-4819-157-8-201210160-00006
10.15585/mmwr.mm6518a2
10.1016/j.ebiom.2016.08.035
10.1080/09595230801956116
10.1016/S2468-1253(16)30181-9
10.1016/j.jcv.2015.07.197
10.1186/1471-2458-14-645
10.1038/nrgastro.2013.107
10.3325/cmj.2016.57.442
10.1016/j.jhep.2016.08.002
10.1371/journal.pone.0101554
10.1016/j.drugpo.2015.05.001
10.1093/ofid/ofv162
10.1016/j.drugpo.2017.07.002
10.1111/jvh.12350
10.1111/1753-6405.12560
10.1007/s10900-014-9932-9
ContentType Journal Article
CorporateAuthor LiveRLife Study Group
CorporateAuthor_xml – sequence: 0
  name: LiveRLife Study Group
– name: LiveRLife Study Group
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1093/infdis/jiy114
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 1896
ExternalDocumentID 10_1093_infdis_jiy114
29534185
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
1KJ
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABBHK
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABQNK
ABTLG
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADACV
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
ECM
EE~
EIF
EJD
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NPM
NU-
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
ZKG
~91
AAYXX
ABEJV
AHMMS
CITATION
7X8
ID FETCH-LOGICAL-c332t-c568b56c8773ab8fdd898c30e7d5b8759e2ee783944ed25ed43bcb6b3276d8553
ISSN 0022-1899
IngestDate Wed Dec 04 04:01:31 EST 2024
Fri Dec 06 03:31:05 EST 2024
Wed Oct 16 00:51:16 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License https://academic.oup.com/journals/pages/about_us/legal/notices
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c332t-c568b56c8773ab8fdd898c30e7d5b8759e2ee783944ed25ed43bcb6b3276d8553
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://academic.oup.com/jid/article-pdf/217/12/1889/24862761/jiy114.pdf
PMID 29534185
PQID 2013784583
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2013784583
crossref_primary_10_1093_infdis_jiy114
pubmed_primary_29534185
PublicationCentury 2000
PublicationDate 2018-05-25
PublicationDateYYYYMMDD 2018-05-25
PublicationDate_xml – month: 05
  year: 2018
  text: 2018-05-25
  day: 25
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2018
References 30242408 - Ann Intern Med. 2018 Sep 18;169(6):JC35
29534217 - J Infect Dis. 2018 May 25;217(12):1858-1860
McHugh ( key 20180525061818_CIT0027) 2017; 55
Grebely ( key 20180525061818_CIT0030) 2017; 2
Yehia ( key 20180525061818_CIT0010) 2014; 9
World Health Organization ( key 20180525061818_CIT0009)
Day ( key 20180525061818_CIT0029) 2008; 20
Janjua ( key 20180525061818_CIT0014) 2016; 12
Cepheid ( key 20180525061818_CIT0033) 2016
Soulier ( key 20180525061818_CIT0026) 2016; 213
Easterbrook ( key 20180525061818_CIT0008) 2016; 65
Chevaliez ( key 20180525061818_CIT0025) 2016; 22
Smith ( key 20180525061818_CIT0022) 2011; 53
Polaris Observatory HCV Collaborators ( key 20180525061818_CIT0007) 2017; 2
Snow ( key 20180525061818_CIT0013) 2016; 41
Saraswat ( key 20180525061818_CIT0003) 2015; 22
Iversen ( key 20180525061818_CIT0015) 2017; 47
Hayes ( key 20180525061818_CIT0036) 2014; 14
Coats ( key 20180525061818_CIT0017) 2015; 26
Morano ( key 20180525061818_CIT0018) 2014; 39
Smith ( key 20180525061818_CIT0023) 2011; 204
Bottero ( key 20180525061818_CIT0019) 2015; 2
Jewett ( key 20180525061818_CIT0021) 2012; 54
Patel ( key 20180525061818_CIT0011) 2016; 131
World Health Organization ( key 20180525061818_CIT0032) 2010
Mera ( key 20180525061818_CIT0012) 2016; 65
Liakina ( key 20180525061818_CIT0004) 2015; 22
Shivkumar ( key 20180525061818_CIT0024) 2012; 157
Marshall ( key 20180525061818_CIT0031) 2015; 26
McHugh ( key 20180525061818_CIT0034) 2015; 70
White ( key 20180525061818_CIT0035) 2008; 27
McAllister ( key 20180525061818_CIT0020) 2014; 61
Hajarizadeh ( key 20180525061818_CIT0001) 2013; 10
Gupta ( key 20180525061818_CIT0028) 2017; 88
Gower ( key 20180525061818_CIT0002) 2014; 61
Bajis ( key 20180525061818_CIT0016) 2017; 47
Bruggmann ( key 20180525061818_CIT0005) 2014; 21
Lazarus ( key 20180525061818_CIT0006) 2016; 57
References_xml – volume: 53
  start-page: 780
  year: 2011
  ident: key 20180525061818_CIT0022
  article-title: Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir499
  contributor:
    fullname: Smith
– volume: 21
  start-page: 5
  year: 2014
  ident: key 20180525061818_CIT0005
  article-title: Historical epidemiology of hepatitis C virus (HCV) in selected countries
  publication-title: J Viral Hepat
  doi: 10.1111/jvh.12247
  contributor:
    fullname: Bruggmann
– volume: 55
  start-page: 1550
  year: 2017
  ident: key 20180525061818_CIT0027
  article-title: Multicenter evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02460-16
  contributor:
    fullname: McHugh
– volume: 131
  start-page: 12
  year: 2016
  ident: key 20180525061818_CIT0011
  article-title: Results of hepatitis C birth-cohort testing and linkage to care in selected U.S. sites, 2012–2014
  publication-title: Public Health Rep
  doi: 10.1177/00333549161310S203
  contributor:
    fullname: Patel
– ident: key 20180525061818_CIT0009
  contributor:
    fullname: World Health Organization
– volume: 213
  start-page: 1087
  year: 2016
  ident: key 20180525061818_CIT0026
  article-title: Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiv423
  contributor:
    fullname: Soulier
– volume: 2
  start-page: 514
  year: 2017
  ident: key 20180525061818_CIT0030
  article-title: Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(17)30075-4
  contributor:
    fullname: Grebely
– volume: 61
  start-page: 359
  year: 2014
  ident: key 20180525061818_CIT0020
  article-title: Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2014.09.004
  contributor:
    fullname: McAllister
– volume: 88
  start-page: 46
  year: 2017
  ident: key 20180525061818_CIT0028
  article-title: Point-of-care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2017.01.006
  contributor:
    fullname: Gupta
– volume: 22
  start-page: 4
  year: 2015
  ident: key 20180525061818_CIT0004
  article-title: Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3
  publication-title: J Viral Hepat
  doi: 10.1111/jvh.12475
  contributor:
    fullname: Liakina
– volume: 204
  start-page: 825
  year: 2011
  ident: key 20180525061818_CIT0023
  article-title: Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jir422
  contributor:
    fullname: Smith
– volume: 47
  start-page: 77
  year: 2017
  ident: key 20180525061818_CIT0015
  article-title: Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
  publication-title: Int J Drug Policy
  doi: 10.1016/j.drugpo.2017.05.022
  contributor:
    fullname: Iversen
– volume: 22
  start-page: 459.e1
  year: 2016
  ident: key 20180525061818_CIT0025
  article-title: Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2016.01.009
  contributor:
    fullname: Chevaliez
– volume: 26
  start-page: 984
  year: 2015
  ident: key 20180525061818_CIT0031
  article-title: Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study
  publication-title: Int J Drug Policy
  doi: 10.1016/j.drugpo.2015.07.002
  contributor:
    fullname: Marshall
– volume: 54
  start-page: 213
  year: 2012
  ident: key 20180525061818_CIT0021
  article-title: Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2012.04.003
  contributor:
    fullname: Jewett
– volume: 61
  start-page: S45
  year: 2014
  ident: key 20180525061818_CIT0002
  article-title: Global epidemiology and genotype distribution of the hepatitis C virus infection
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.07.027
  contributor:
    fullname: Gower
– volume: 20
  start-page: 116
  year: 2008
  ident: key 20180525061818_CIT0029
  article-title: Experience of hepatitis C testing among injecting drug users in Sydney, Australia
  publication-title: AIDS Care
  doi: 10.1080/09540120701426524
  contributor:
    fullname: Day
– volume: 157
  start-page: 558
  year: 2012
  ident: key 20180525061818_CIT0024
  article-title: Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-157-8-201210160-00006
  contributor:
    fullname: Shivkumar
– volume: 65
  start-page: 461
  year: 2016
  ident: key 20180525061818_CIT0012
  article-title: Identification and clinical management of persons with chronic hepatitis C virus infection - Cherokee Nation, 2012–2015
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6518a2
  contributor:
    fullname: Mera
– volume: 12
  start-page: 189
  year: 2016
  ident: key 20180525061818_CIT0014
  article-title: The population level cascade of care for hepatitis C in BRITISH Columbia, Canada: the BC hepatitis testers cohort (BC-HTC)
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.08.035
  contributor:
    fullname: Janjua
– volume: 27
  start-page: 666
  year: 2008
  ident: key 20180525061818_CIT0035
  article-title: Acceptability of hepatitis C virus testing methods among injecting drug users
  publication-title: Drug Alcohol Rev
  doi: 10.1080/09595230801956116
  contributor:
    fullname: White
– volume: 2
  start-page: 161
  year: 2017
  ident: key 20180525061818_CIT0007
  article-title: Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(16)30181-9
  contributor:
    fullname: Polaris Observatory HCV Collaborators
– volume: 70
  start-page: S84
  year: 2015
  ident: key 20180525061818_CIT0034
  article-title: Evaluation of the cepheid Xpert® HCV viral load assay
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2015.07.197
  contributor:
    fullname: McHugh
– volume-title: Xpert® HCV Viral Load
  year: 2016
  ident: key 20180525061818_CIT0033
  contributor:
    fullname: Cepheid
– volume: 14
  start-page: 645
  year: 2014
  ident: key 20180525061818_CIT0036
  article-title: Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-14-645
  contributor:
    fullname: Hayes
– volume: 10
  start-page: 553
  year: 2013
  ident: key 20180525061818_CIT0001
  article-title: Epidemiology and natural history of HCV infection
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.107
  contributor:
    fullname: Hajarizadeh
– volume: 57
  start-page: 442
  year: 2016
  ident: key 20180525061818_CIT0006
  article-title: Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe
  publication-title: Croat Med J
  doi: 10.3325/cmj.2016.57.442
  contributor:
    fullname: Lazarus
– volume: 65
  start-page: 46
  year: 2016
  ident: key 20180525061818_CIT0008
  article-title: Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.08.002
  contributor:
    fullname: Easterbrook
– volume: 9
  start-page: e101554
  year: 2014
  ident: key 20180525061818_CIT0010
  article-title: The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0101554
  contributor:
    fullname: Yehia
– volume-title: WHO guidelines on drawing blood: best practices in phlebotomy. 7 capillary sampling
  year: 2010
  ident: key 20180525061818_CIT0032
  contributor:
    fullname: World Health Organization
– volume: 26
  start-page: 1050
  year: 2015
  ident: key 20180525061818_CIT0017
  article-title: The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature
  publication-title: Int J Drug Policy
  doi: 10.1016/j.drugpo.2015.05.001
  contributor:
    fullname: Coats
– volume: 2
  start-page: ofv162
  year: 2015
  ident: key 20180525061818_CIT0019
  article-title: Simultaneous human immunodeficiency virus-hepatitis B-hepatitis C point-of-care tests improve outcomes in linkage-to-care: results of a randomized control trial in persons without healthcare coverage
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofv162
  contributor:
    fullname: Bottero
– volume: 47
  start-page: 34
  year: 2017
  ident: key 20180525061818_CIT0016
  article-title: Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review
  publication-title: Int J Drug Policy
  doi: 10.1016/j.drugpo.2017.07.002
  contributor:
    fullname: Bajis
– volume: 22
  start-page: 6
  year: 2015
  ident: key 20180525061818_CIT0003
  article-title: Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2
  publication-title: J Viral Hepat
  doi: 10.1111/jvh.12350
  contributor:
    fullname: Saraswat
– volume: 41
  start-page: 193
  year: 2016
  ident: key 20180525061818_CIT0013
  article-title: Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001–2012: a multi-level modelling analysis
  publication-title: Aust N Z J Public Health
  doi: 10.1111/1753-6405.12560
  contributor:
    fullname: Snow
– volume: 39
  start-page: 922
  year: 2014
  ident: key 20180525061818_CIT0018
  article-title: Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic
  publication-title: J Community Health
  doi: 10.1007/s10900-014-9932-9
  contributor:
    fullname: Morano
SSID ssj0004367
Score 2.604983
Snippet Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 1889
SubjectTerms Adult
Australia
Biological Assay - methods
Blood Specimen Collection - methods
Cohort Studies
Female
Hepacivirus - genetics
Hepatitis C - virology
Humans
Male
Middle Aged
Point-of-Care Systems
Point-of-Care Testing
RNA, Viral - genetics
Sensitivity and Specificity
Serologic Tests - methods
Viral Load - methods
Title Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay
URI https://www.ncbi.nlm.nih.gov/pubmed/29534185
https://search.proquest.com/docview/2013784583
Volume 217
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEIiXCQaMjjEZCfFSZWviOHEe2UcpsCGkfahvkR07WotIpjZ92P4K_mTu4nx1KtLgJYos2VF8P5_Pd_7dEfJhaMQwBUvXScAedXxYE45iXDlD43Pp4yYukO989j0YX_pfJ3zS6_3u3FpaFmo_uVvLK_kfqUIbyBVZsv8g2WZQaIB3kC88QcLwfJCMT5pU3XWof3Jj5sVgfHQ1uJoi9f40l3owsq67c-j_c_Ajn2aFk6cOMo9QOnIlsNtSxapsEvau1nJRh3IaG_xU_sqrIHxZnSOfLvBOf-sandn0BefyWs5bRTeDw_md1KZ05xyaa3hvveLzBdZ2scSbsjbicdcr4QoMqFsGc4cl4Apb_Gjf1Mo1dMAeYF3t61nqZg0zr6NMXSGizsYMowVrlb5NiAVNGv9rNJveupaYuppe-96211xGtGF4FtsBYtv9EXmMqRWxGsPxl28t05YFYZ1_Hv-uytoK3Q9s9wPbfdXK-cvRpTRhLp6TzUqs9JMF0gvSM9kWeWKrkd5ukadn1T2Ll-RziyyapxSQRUtkUUAWLZFFEVm0iyy6gixaIusVuRydXByNnarkBqxV5hVOwgOheJCIMGRSiVRrEQlYxibUXMHRNjKeMaFANrXRHjfaZypRgWJeGGjBOXtNNrI8M28ITaNhIMLEqARUfiS1cGF3SYQPWsPz08D0ycd6iuIbm1klXiuKPnlfT2AMug8DWjIzAPzYw3yZAiP_fbJtZ7YZyos4w8RMOw_9zFvyrAXyLtko5kvzDgzOQu2VGPgD3O2Bzg
link.rule.ids 314,780,784,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+Xpert+HCV+Viral+Load+Finger-Stick+Point-of-Care+Assay&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Lamoury%2C+Francois+M+J&rft.au=Bajis%2C+Sahar&rft.au=Hajarizadeh%2C+Behzad&rft.au=Marshall%2C+Alison+D&rft.date=2018-05-25&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=217&rft.issue=12&rft.spage=1889&rft.epage=1896&rft_id=info:doi/10.1093%2Finfdis%2Fjiy114&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_infdis_jiy114
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon